UA102523C2 - Use of myeloperoxidase inhibitors for the treatment of multiple system atrophy - Google Patents

Use of myeloperoxidase inhibitors for the treatment of multiple system atrophy

Info

Publication number
UA102523C2
UA102523C2 UAA201000936A UAA201000936A UA102523C2 UA 102523 C2 UA102523 C2 UA 102523C2 UA A201000936 A UAA201000936 A UA A201000936A UA A201000936 A UAA201000936 A UA A201000936A UA 102523 C2 UA102523 C2 UA 102523C2
Authority
UA
Ukraine
Prior art keywords
treatment
multiple system
system atrophy
myeloperoxidase inhibitors
inhibitors
Prior art date
Application number
UAA201000936A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Гакан Эрикссон
Вернер Поэв
Original Assignee
Астразенека Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Астразенека Аб filed Critical Астразенека Аб
Priority claimed from PCT/SE2008/050950 external-priority patent/WO2009025618A1/en
Publication of UA102523C2 publication Critical patent/UA102523C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The present invention relates to the use of 2-thioxo-l, 2,3,5-tetrahydro-pyrrolo[3,2-d]pyrimidine-4-one, thioxan-thine and 2-thioxo-],2,3,7-tetrahydro-6H-purin-6-one derivatives as MPO inhibitors for the treatment of multiple system atrophy (MSA), Huntington' s disease (HD).
UAA201000936A 2007-08-23 2008-08-22 Use of myeloperoxidase inhibitors for the treatment of multiple system atrophy UA102523C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95752307P 2007-08-23 2007-08-23
PCT/SE2008/050950 WO2009025618A1 (en) 2007-08-23 2008-08-22 Mipo inhibitors for the treatment of huntington's disease and multiple system atrophy

Publications (1)

Publication Number Publication Date
UA102523C2 true UA102523C2 (en) 2013-07-25

Family

ID=52023868

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201000936A UA102523C2 (en) 2007-08-23 2008-08-22 Use of myeloperoxidase inhibitors for the treatment of multiple system atrophy

Country Status (1)

Country Link
UA (1) UA102523C2 (en)

Similar Documents

Publication Publication Date Title
PH12014501180A1 (en) New use 938
UA102251C2 (en) Aminidihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease
HK1136283A1 (en) Compounds for the prevention and treatment of cardiovascular diseases
PL2026803T3 (en) Compositions of r(+) and s(-) pramipexole and methods of using the same
SG170024A1 (en) Imidazole-based compounds, compositions comprising them and methods of their use
TN2011000259A1 (en) Substituted pyrimidines for the treatment of diseases such as cancer
MX2009004060A (en) Triazolo-pyridazine protein kinase modulators.
MY150518A (en) Substituted gamma lactams as therapeutic agents
PL1979355T3 (en) Spiro imidazole derivatives as ppar modulators
MX2010006241A (en) Aminotriazole derivatives as alx agonists.
MX349556B (en) Aminopyrimidine derivatives as lrrk2 modulators.
GEP20125647B (en) Kinesin inhibitors as cancer therapeutics
MY147890A (en) 9-(pyrazol-3-yl)-9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidaz0 [4,5-b] pyridin-5-amine derivatives and their use for the treatment of cancer
MX2010000098A (en) Polycyclic guanine derivatives and use thereof.
IL193479A0 (en) Modulators of muscarinic receptors
MX2010006206A (en) 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases.
AU2010306870A8 (en) Reducing the risk of pathological effects of traumatic brain injury
EP2223712A4 (en) Fiber construct for treating biological components
PH12014500079A1 (en) 6-substituted phenoxychroman carboxylic acid derivatives
TW200942548A (en) Thiazolyl-dihydro-indazoles
EP2590652A4 (en) Pharmaceutical compositions containing vanoxerine
WO2010085799A9 (en) Compositions and method for the treatment of parkinson's disease
GB2459808A (en) Novel benzothiazole and benzoxazole linked pyrrolo (2,1-C) (1,4) benzodiazepine hybrids as novel antitumour agents and process for the preparation thereof
UA103197C2 (en) Use of nifurtimox for the treatment of diseases caused by trichomonadida
UA102523C2 (en) Use of myeloperoxidase inhibitors for the treatment of multiple system atrophy